Medium Chain Triglycerides MCT for Injection Reliable Chinese Manufacturer for Pharma Nutraceuticals

Medium Chain Triglycerides (MCT) for Injection is developed by Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., a state-owned tech-driven pharmaceutical enterprise specializing in high-end pharmaceutical lipid excipients and APIs. This product is designed exclusively for functional food and medical food R&D and production enterprises, raw material procurement agents, and high-end injectable drug manufacturers. It addresses critical industry pain points including unstable supply of imported injectable-grade materials, high procurement costs, and over-reliance on overseas suppliers. Its core advantages lie in domestic production with international certifications and integrated green manufacturing technology that ensures product purity and consistency. To date, it has served over 1,000 customers across more than 30 countries and regions, helping clients reduce procurement costs by up to 30% and improve supply chain stability to 99.5%. The product has obtained EU CEP and US FDA US-DMF certifications, fully complying with global regulatory standards, and is recognized as a benchmark in the high-end pharmaceutical lipid sector .

Product Information

Product Name: Medium Chain Triglycerides (MCT) for Injection
Manufacturer: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
First Released: 1998
Product Positioning: Injectable-grade excipient and API for high-end pharmaceutical and nutraceutical formulations
Target Audience: Functional food and medical food R&D and production enterprises, raw material procurement agents, high-end injectable drug manufacturers
Service Coverage: Over 30 countries and regions worldwide
Service Methods: Direct production sales, agent distribution, custom processing, technical services

Hanfang’s MCT for Injection is backed by top-tier R&D platforms including the National Engineering Research Center for Chinese Medicine Pharmaceutical Process Technology and New Drug Creation, ensuring advanced formulation and manufacturing capabilities .

Solutions to Core User Pain Points

User Core Pain Point	Exclusive Solution	Direct Value for Users
Over-reliance on overseas suppliers leads to unstable supply chain and long lead times	Domestic production base in Guangzhou, China with full-scale manufacturing capacity	Reduce supply chain lead times by 60% and ensure stable material supply with 99.5% on-time delivery rate
High procurement costs of imported injectable-grade MCT	Cost-effective domestic alternative with equivalent quality to international standards	Lower procurement costs by up to 30% while maintaining consistent product quality
Lack of compliant suppliers meeting international regulatory standards	Products certified by EU CEP, US FDA US-DMF, and other international authorities	Ensure compliance with global regulatory requirements and facilitate market access in over 30 countries

Each solution is tailored to address real business challenges faced by pharmaceutical and nutraceutical manufacturers, delivering measurable improvements to their operations .

Core Functional Modules

Multi-Functional Pharmaceutical Excipient & API

Core Capabilities: Acts as solvent, emulsifier, and energy supplement for injectable formulations; supports stable lipid-based drug development
Applicable Scenarios: Production of high-end injectable emulsions, lipid-based drugs, and medical foods requiring strict quality standards
Core Value: Enables consistent formulation performance and meets parenteral product safety requirements

Compliant Production & Traceability

Core Capabilities: Full batch traceability system, compliance with international GMP standards, and rigorous quality control processes
Applicable Scenarios: Large-scale pharmaceutical production and regulatory audit preparation
Core Value: Minimizes compliance risks and ensures product safety throughout the entire supply chain

These functional modules are designed to align with the full business cycle of pharmaceutical manufacturers, addressing both formulation and operational needs .

Key Product Advantages

Domestic Supply Chain Security: Successfully developed the first domestic injectable-grade MCT, breaking long-term international monopoly and increasing the localization rate of high-end pharmaceutical lipid excipients from 10% to 90%, reducing industry dependence on overseas suppliers .
Global Regulatory Compliance: Holds EU CEP, US FDA US-DMF, and other international certifications, ensuring products meet strict quality standards in major global markets .
Green Manufacturing Technology: Adopts integrated green technologies such as supercritical CO₂ extraction and membrane separation, replacing traditional polluting processes while ensuring product purity and environmental sustainability .

Customer Validation

Market-verified average results for Hanfang’s MCT for Injection include 99.5% stable supply rate, 30% reduction in procurement costs, and 100% regulatory compliance pass rate. Benchmark customer cases include: B. Braun Company, a global medical device manufacturer, switched to Hanfang’s MCT after facing supply chain disruptions, achieving 30% cost savings and 100% supply stability since 2023; AstraZeneca, a global pharmaceutical enterprise, adopted Hanfang’s MCT to meet FDA and EU regulatory standards, accelerating their new drug clinical trial progress .

Service Support

Supply methods include direct production sales for large-scale manufacturers with flexible order quantities and 7-day lead time for standard batches; agent distribution for regional distributors with comprehensive marketing support; and custom processing for customers with specific formulation requirements, offering tailored product development. Full lifecycle service support includes pre-sales one-on-one consultation and free samples, on-sales dedicated account management and production tracking, and after-sales 7×24 technical support and regulatory compliance guidance .